Pigmented progressive purpuric dermatosis
https://en.wikipedia.org/wiki/Pigmented_purpuric_dermatosis
☆ Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ. 
Schamberg disease - nwoke dị afọ 26 nwere patch nke asymptomatic pigmentation na telangiectasia n'ụkwụ.
relevance score : -100.0%
References
Pigmented Purpuric Dermatoses: A Complete Narrative Review 34070260 NIH
Pigmented purpuric dermatoses (PPD) bụ otu ọnọdụ akpụkpọ ahụ nwere obere akụkụ ọbara ọgbụgba n'okpuru akpụkpọ ahụ n'ihi mbufụt nke capillary. PPD na-amalite dị ka ntụpọ ọbara ọbara ruo odo odo nke na-emesị ghọọ ọla edo-aja aja ka hemosiderin na-emegharịghachi.
Pigmented purpuric dermatoses (PPD) include several skin diseases characterized by multiple petechial hemorrhage as consequence of capillaritis. PPD generally present with red to purple macules that progressively evolve to golden-brown color as the hemosiderin is reabsorbed.
Schamberg Disease 32809367 NIH
Schamberg disease bụ ụdị pigmented purpuric dermatoses (PPDs) a na-ahụkarị, nke bụ ọnọdụ akpụkpọ ahụ na-adịghị ala ala nke nwere obere ntụpọ ọbara ọbara ma ọ bụ odo odo, yana mmụba akpụkpọ ahụ (patches nke aja aja, ọbara ọbara ma ọ bụ odo) . A na-ekewa PPD n'ime ụdị ise: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura, eczematoid-like purpura of Doucas and Kapetanakis. A na-akpọkwa progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressiva, Schamberg's purpura Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura, eczematoid-like purpura of Doucas and Kapetanakis. Ọ na-emetụtakarị ụmụ nwoke ma na-apụtakarị n'ụkwụ ala, mana ọ nwekwara ike ime n'apata ụkwụ, ukwu, ogwe, ma ọ bụ ogwe aka.
Schamberg disease represents the most common type of pigmented purpuric dermatoses (PPDs), a chronic, benign, cutaneous eruptions characterized by petechiae, purpura, and increased skin pigmentation (brown, red, or yellow patchy). The PPDs are grouped into five clinical entities: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura and, eczematoid-like purpura of Doucas and Kapetanakis. Schamber disease (SD) has also been called: progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressive and, Schamberg's purpura. It is commonly seen in males and mainly affects the tibial regions, and could involve thighs, buttocks, trunk, or upper extremities.
Characteristics and Clinical Manifestations of Pigmented Purpuric Dermatosis 26273156 NIH
A tụlere ozi gbasara ndị ọrịa 113 nwere PPD, gụnyere 38 bụ ndị mere biopsy anụ ahụ maka ọmụmụ ihe a. Ụdị ọgwụgwọ a na-ahụkarị bụ ọrịa Schamberg (60. 5%) . Ọnọdụ ndị ọzọ n'akụkụ PPD bụ ọbara mgbali elu (15. 8%) , ọrịa shuga (10. 5%) , na ndị ọzọ. Akụkọ banyere ọgwụ ekpughere statins (13. 2%) , beta blockers (10. 5%) , na ndị ọzọ. Ihe nwere ike ime jikọtara na PPD gụnyere ọrịa iku ume elu na nso nso a (5. 3%) , ogologo ogologo oge na-eduga na nrụgide orthostatic dị elu (2. 6%) , na mmega ahụ siri ike (2. 6%) . Enyere ndị ọrịa 36 ọgwụgwọ (94. 7%) - oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.
Information on 113 patients with PPD was analyzed, and 38 subjects with skin biopsy were included for this study. Schamberg's disease was the most frequent clinical type (60.5%). Concomitant diseases included hypertension (15.8%), diabetes (10.5%), and others. Associated medication histories included statins (13.2%), beta blockers (10.5%), and others. Possibly associated etiologic factors were recent upper respiratory infection (5.3%), high orthostatic pressure due to prolonged standing (2.6%), and strenuous exercise (2.6%). A total of 36 patients (94.7%) were treated with one or more treatment methods, including oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.
○ Ọgwụgwọ ― OTC Ọgwụ
OTC steroid ude
#Hydrocortisone ointment
#Hydrocortisone cream